Infection Current Awareness Update 06/09/2021
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Infection Current Awareness Update – 06/09/2021 Welcome to the weekly Infection Current Awareness Update (ICAU), produced by PHE Knowledge and Library Services. The purpose of this update is to provide you with the latest, best evidence about infection, to help you make informed decisions. Please note: PHE KLS has set up a separate COVID-19 Daily Alert of latest research. If you would like to receive this, please email libraries@phe.gov.uk. In addition to this, a page of resources about the coronavirus is available here. If you have any queries, please contact us at libraries@phe.gov.uk, and if you would like to request a literature search, please use the Knowledge and Library Services Enquiries Portal (PHE staff only). Please note that not all the articles and resources referred to in this alert are freely available. Some articles may require an Athens username and password, and for PHE and NHS staff, these can be obtained here. If you do not work for PHE or the NHS, you may want to approach your local health library service to discuss how you may have access to library services. COVID-19 related research • COVID-19 infection - 3 Infection-related guidance • American Society for Microbiology - 1 • British Association for Sexual Health and HIV - 1 • British Society for Antimicrobial Chemotherapy - 1 • Infectious Diseases Society of America - 1 • Royal College of General Practitioners - 1 Infection-related journals • American Journal of Infection Control - 4 • Clinical Infectious Diseases - Advance Access - 26 • Clinical Infectious Diseases - Current Issue - 10 • Clinical Microbiology and Infection - 3 • Current Opinion in Microbiology - 1 • Diagnostic Microbiology and Infectious Disease - 3 • Emerging Infectious Diseases Journal - ahead of print - 19 • Eurosurveillance latest updates - 6 • Infection - 3 • Infection Control & Hospital Epidemiology - FirstView Article - 2 • International Journal of Infectious Diseases - 13 • Journal of Clinical Microbiology - 5 • Journal of Clinical Virology - 3 • Journal of Hospital Infection - 4 • Journal of Infection - 7 • Journal of Infection Prevention - 2 • Journal of Microbiology, Immunology and Infection - 7 • Journal of Virology Current Issue - 11 • Microbiology and Molecular Biology Reviews: Current Issue - 1 • Morbidity and Mortality Weekly Report (MMWR) - 9 • Nature Reviews Microbiology - Current Issue - 1 • New England Journal of Medicine - Current Issue - 3 • Scandinavian Journal of Infectious Diseases: Table of Contents - 15 • Sexually Transmitted Infection Online First - 3 NIS Affiliation • PubMed: NIS affiliation - 6
COVID-19 related research
COVID-19 infection
RT @CochraneLibrary: Main @Cochrane_IDG authors, Maria Popp &
Stephanie Weibel said: “Current evidence does not support using #ivermectin
for treating or preventing of #COVID19 unless they are part of well-designed
randomized trials.” https://t.co/FR6Lc5HB7J 3/4 https://t.co/K6L3vCACIS
02 Sep 2021
RT @CochraneLibrary: Main @Cochrane_IDG authors, Maria Popp & Stephanie Weibel said:
“Current evidence does not support using #ivermectin for treating or preventing of #COVID19 unless
they are part of well-designed randomized trials.”
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub2/full 3/4
PODCAST - Listen to this new @CochraneLibrary #podcast on #ivermectin
for preventing and treating #COVID19. Hear from @Cochrane_IDG author
Maria Popp about the recent @cochranecollab review findings:
https://t.co/dnz3LCQMlT https://t.co/CBB7Xgoran
01 Sep 2021
PODCAST - Listen to this new @CochraneLibrary #podcast on #ivermectin for preventing and
treating #COVID19. Hear from @Cochrane_IDG author Maria Popp about the recent
@cochranecollab review findings: https://buff.ly/3geEEgb
Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of
Residential Colleges in Fall 2021
30 Aug 2021
Annals of Internal Medicine, Ahead of Print.
[back to top]
Infection-related guidance
American Society for Microbiology
Guidelines for the Detection and Identification of Group B Streptococcus
29 Jul 2021
Updated July 2021. Streptococcus agalactiae or Group B Streptococcus (GBS) has long been a
leading cause of neonatal infection. ASM is responsible for maintaining and updating guidelines for
standard laboratory practices related to detection and identification of GBS.
[back to top]
British Association for Sexual Health and HIV
The BASHH Guidelines for the Management of Sexual Assault are now
available for consultation. Please navigate to the Documents for Consultation
section.
31 Aug 2021
[back to top]
British Society for Antimicrobial ChemotherapyAMR risk: National blood tube shortage highlights vital importance of testing
to fight infection
02 Sep 2021
The UK Government is supporting action to alleviate the current national shortage of test tubes,
which has resulted in widespread disruption to testing around the country.
[back to top]
Infectious Diseases Society of America
CID: COVID-19 surges adversely impacted rates of health care-associated
infections and clusters of infections within hospitals, emphasizing the need to
balance COVID demands with routine hospital infection prevention.
:https://t.co/tfW5Ud4mqd #IDSAJournals #ClinInfectDis
https://t.co/7qe2kE8rNv
05 Sep 2021
CID: COVID-19 surges adversely impacted rates of health care-associated infections and clusters of
infections within hospitals, emphasizing the need to balance COVID demands with routine hospital
infection prevention. :https://bit.ly/2VdYlxz #IDSAJournals #ClinInfectDis
[back to top]
Royal College of General Practitioners
College defends GPs against media criticism of remote consulting
30 Aug 2021
Responding to coverage of House of Commons Library figures on remote consultations in sections of
the media over the weekend, Professor Martin Marshall, Chair of the Royal College of GPs, appeared
on BBC Radio 4’s influential PM programme to defend GPs against unfair criticism and set out the
College’s position on remote consulting
[back to top]
Infection-related journals
American Journal of Infection Control
Proposed Metrics to Benchmark Antibiotic Prescribing in Pediatric Outpatient
Settings
04 Sep 2021
Metrics to track and compare outpatient pediatric antibiotic prescribing are needed to improve
antibiotic use and prevent unwanted consequences of antibiotic overuse. We have considered the
impact and feasibility of available metrics and propose select high-priority measures for electronic
reporting of pediatric outpatient antibiotic use
Impact of sterile gloves on blood-culture contamination rates: A randomized
clinical trial
04 Sep 2021
Blood-cultures (BC) are one of the most important laboratory tests to diagnose bacteremia, however
their contamination limits its prognostic value and constitutes a challenge to health services.1 Studies
show that up to 50% of all positive blood cultures are contaminated
A Novel Framework to Guide Antibiotic Stewardship Nursing Practice
04 Sep 2021
Antibiotic resistance (ABR) is one of the most vexing problems facing humanity. It is a silent
pandemic poised to reverse a century of medical progress, rendering antibiotics ineffective in treating
even the most common infectious diseasesThe Effect of Disinfectants on the Microbial Community on Environmental
Healthcare Surfaces using Next Generation Sequencing
02 Sep 2021
Globally, healthcare-associated infections (HAIs) remain a significant burden. Within the United
States, approximately 687,200 HAIs are diagnosed in hospitalized patients annually, with deaths in
11% of these patients1. Additionally, the direct medical costs of HAIs to U.S. hospitals can exceed
$35 billion for inpatient services2
[back to top]
Clinical Infectious Diseases - Advance Access
Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A
Notifications in New Zealand
04 Sep 2021
AbstractNew Zealand (NZ) became one of few countries to shift from PCV13 to PCV10 in 2017. The
number of serotype 19A cases in young children and the proportion of isolates that are penicillin-
resistant have been steadily increasing since. It is time for NZ to reconsider its choice of
pneumococcal vaccine.
Rapid emergence and spread of SARS-CoV-2 gamma (P.1) variant in Haiti
02 Sep 2021
AbstractAfter an initial wave of COVID-19 in Haiti in summer 2020 (primarily lineage B.1),
seropositivity for anti-SARS-CoV-2 IgG was ~40%. Variant P.1 (gamma) was introduced in February
2021, with an initially limited introduction followed by exponential local dissemination within this
unvaccinated population with prior exposure to earlier SARS-CoV-2 lineages.
Association of E484K spike protein mutation with SARS-CoV-2 infection in
vaccinated persons---Maryland, January – May 2021
02 Sep 2021
AbstractAmong 9,048 people infected with SARS-CoV-2 between January-May, 2021 in Maryland, in
regression-adjusted analysis, SARS-CoV-2 viruses carrying the spike protein mutation E484K were
disproportionately prevalent among persons infected after full vaccination against COVID-19 as
compared to infected persons who were not fully vaccinated (aOR 1.96, 95% CI, 1.36 to 2.83).
Similar antibody responses against SARS-CoV-2 in HIV uninfected and
infected individuals on antiretroviral therapy during the first South African
infection wave
02 Sep 2021
AbstractBackgroundThere is limited understanding of SARS-CoV-2 pathogenesis in African
populations with a high burden of infectious disease comorbidities such as HIV. The kinetics,
magnitude and duration of virus-specific antibodies and the underlying B cell responses in people
living with HIV (PLWH) in sub-Saharan Africa have not been fully characterized
Evolution of COVID-19 symptoms during the first 12 months after illness
onset
02 Sep 2021
AbstractBackgroundFew robust longitudinal data on long-term COVID-19 symptoms are available.
We evaluated symptom onset, severity and recovery across the full spectrum of disease severity, up
to one year after illness onset.MethodsThe RECoVERED Study is a prospective cohort study based
in Amsterdam, the Netherlands
Fostamatinib for the treatment of hospitalized adults with COVD-19 A
randomized trial
01 Sep 2021
AbstractBackgroundCoronavirus Disease 2019 (Covid-19) requiring hospitalization is characterized
by robust antibody production, dysregulated immune response and immunothrombosis. Fostamatinib,
is a novel spleen tyrosine kinase inhibitor we hypothesize will ameliorate Fc activation and attenuate
harmful effects of the anti-COVID-19 immune response
Health Care Personnel (HCP) attitudes about COVID-19 vaccination after
emergency use authorization
01 Sep 2021AbstractBackgroundWe previously reported on COVID-19 vaccination intent among HCP before emergency use authorization. We found widespread hesitancy and a substantial proportion of HCP did not intend to vaccinate.MethodsWe conducted a cross-sectional survey of HCP, including clinical and non-clinical staff, researchers, and trainees between February 21 and March 19, 2021 Maternal HIV drug resistance is associated with vertical transmission and is prevalent in infected infants 01 Sep 2021 AbstractBackgroundWe aimed to assess if maternal HIV drug resistance is associated with an increased risk of HIV vertical transmission and to describe the dynamics of drug resistance in HIV- infected infants.MethodsA case-control study of PROMISE study participants Ibrexafungerp versus placebo for vulvovaginal candidiasis treatment: a phase 3, randomized, controlled superiority trial (VANISH 303) 01 Sep 2021 AbstractBackgroundCurrent treatment of vulvovaginal candidiasis (VVC) is largely limited to azole therapy. Ibrexafungerp is a first-in-class triterpenoid antifungal with broad-spectrum anti-Candida fungicidal activity. The objective of this study was to evaluate the efficacy and safety of ibrexafungerp compared with placebo in patients with acute VVC Human filariasis in travelers and migrants: a retrospective 25-year analysis at the Institute of Tropical Medicine, Antwerp, Belgium 31 Aug 2021 AbstractBackgroundInformation on human filariasis in international travelers is scarce. We describe the epidemiology, clinical presentation and outcome of these infections in a reference travel clinic over the past decades.MethodsWe reviewed all cases of filariasis diagnosed at the Institute of Tropical Medicine, Antwerp, Belgium, from 1994 to 2018 Reply to author 31 Aug 2021 Envisioning Future UTI Diagnostics 31 Aug 2021 AbstractUrinary tract infections (UTIs) are among the most common bacterial infections in the United States and are a major driver of antibiotic use - both appropriate and inappropriate - across healthcare settings Latino Household Transmission of SARS-CoV-2 31 Aug 2021 AbstractWe assessed temporal changes in the household secondary attack rate of SARS-CoV-2 and identified risk factors for transmission in vulnerable Latino households of Baltimore, Maryland. The household SAR was 45.8%, and it appeared to increase as the alpha variant spread, highlighting the magnified risk of spread in unvaccinated populations. Pathology and Pathogenesis of Lassa Fever: Novel Immunohistochemical Findings in Fatal Cases and Clinico-pathologic Correlation 31 Aug 2021 AbstractBackgroundLassa fever is a zoonotic, acute viral illness first identified in Nigeria in 1969. An estimate shows that the “at risk” seronegative population (in Sierra Leone, Guinea, and Nigeria) may be as high as 59 million, with an annual incidence of all illnesses of three million, and fatalities up to 67,000, demonstrating the serious impact of the disease on the region and global Universal lifelong fungal prophylaxis and risk of coccidioidomycosis in lung transplant recipients living in an endemic area 31 Aug 2021 AbstractBackgroundLung transplant recipients residing in the endemic region are vulnerable to severe morbidity and mortality from Coccidioides. As infection risk persists beyond the first post- transplant year, investigations evaluating extended prophylaxis durations are needed Spatial and genomic data to characterize endemic typhoid transmission 31 Aug 2021 AbstractBackgroundDiverse environmental exposures and risk factors have been implicated in the transmission of Salmonella Typhi, however, the dominant transmission pathways through the environment to susceptible humans remain unknown. Here, we utilize spatial, bacterial genomic, and hydrological data to refine our view of Typhoid transmission in an endemic setting
External Validation and Comparison of Clostridioides difficile Severity Scoring Systems 30 Aug 2021 AbstractBackgroundMany models have been developed to predict severe outcomes from Clostridioides difficile infection. These models are usually developed at a single institution and largely are not externally validated. This aim of this study was to validate previously published risk scores in a multicenter cohort of patients with CDI Microbial Cell-Free DNA Identifies Etiology of Bloodstream Infections, Persists Longer Than Conventional Blood Cultures, and its Duration of Detection is Associated with Metastatic Infection in Patients with Staphylococcus aureus and Gram-Negative Bacteremia 30 Aug 2021 AbstractBackgroundMicrobial cell-free DNA (mcfDNA) sequencing of plasma can identify presence of a pathogen in a host. This study evaluated the duration of pathogen detection by mcfDNA sequencing vs. conventional blood culture in patients with bacteremia Regulatory Level of Evidence and Practicality in Antifungal Use Decisions for Less Common Fungal Diseases 30 Aug 2021 Invasive candidiasis remains the most prevalent healthcare-related fungal infection [1, 2]. The disease state is quite heterogeneous, encompassing catheter-related biofilm infections, intraabdominal infections, and multi-organ disseminated infections. A wide variety of predisposing host factors influence disease manifestations and outcome [3] Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada 30 Aug 2021 AbstractIntroductionIn Canada, first and second doses of mRNA vaccines against SARS-CoV-2 were uniquely spaced 16 weeks apart, but the duration of single-dose protection remains uncertain. We estimated one- and two-dose mRNA vaccine effectiveness (VE) among healthcare workers (HCWs) in Quebec, Canada including protection against varying outcome severity, variants of concern (VOC), and the Impact of Antibiotic Stewardship Rounds in the Intensive Care Setting: a prospective cluster-randomized crossover study 30 Aug 2021 AbstractBackgroundFew groups have formally studied the effect of dedicated antibiotic stewardship rounds (ASRs) on antibiotic use (AU) in intensive care units (ICUs).MethodsWe implemented weekly ASRs using a two-arm, cluster-randomized, crossover study in 5 ICUs at Duke University Hospital from 11/2017 to 6/2018 It’s hard to measure success while caring for surges in COVID-19 hospitalizations 28 Aug 2021 Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis? 28 Aug 2021 myocarditispericarditisSARS-CoV-2COVID-19vaccine National Landscape of HIV+ Deceased Organ Donors in the United States 28 Aug 2021 AbstractBackgroundOrgan transplantation from donors with HIV to recipients with HIV (HIV D+/R+) presents risks of donor-derived infections. Understanding clinical, immunologic, and virologic characteristics of HIV+ donors is critical for safety Estimating the latent period of coronavirus disease 2019 (COVID-19) 28 Aug 2021 AbstractUsing detailed exposure information on COVID-19 cases, we estimated the mean latent period to be 5.5 days (95% confidence interval: 5.1-5.9 days), shorter than the mean incubation
period (6.9 days). Laboratory testing may allow shorter quarantines since 95% of COVID-19 cases
shed virus within 10.6 days (95%CI: 9.6-11.6) of infection.
Novel vector of scrub typhus in subantarctic Chile – evidence from human
exposure
28 Aug 2021
AbstractThe exposure of a research team to chigger mites in southern Chile allowed the first
identification of a trombiculid species as vector and reservoir of scrub typhus outside the
tsutsugamushi triangle, providing unique insights into the ecology and transmission of this recently
discovered rickettsial infection in South America.
[back to top]
Clinical Infectious Diseases - Current Issue
Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in
Low- and Middle-Income Countries: The Importance of Community Mortality
Studies
02 Sep 2021
AbstractThe Bill & Melinda Gates Foundation supported respiratory syncytial virus (RSV) mortality
surveillance studies in several low- and middle-income countries to address the striking gap in
community mortality burden data from these geographies
Association of Respiratory Syncytial Virus Infection and Underlying Risk
Factors for Death Among Young Infants Who Died at University Teaching
Hospital, Lusaka Zambia
02 Sep 2021
AbstractBackgroundRespiratory syncytial virus (RSV) is a leading cause of acute lower respiratory
tract infections and child mortality. While RSV disease burden is highest in low- and middle-income
countries, most knowledge about risk factors for fatal RSV disease comes from high-income settings
Risk Factors for Respiratory Syncytial Virus–Associated Community Deaths in
Zambian Infants
02 Sep 2021
AbstractBackgroundRespiratory syncytial virus (RSV) is a major cause of infant deaths. Its
epidemiology in low- and middle-income countries is poorly understood. Risk factors associated with
RSV-associated infant deaths that occur in community settings are incompletely known
Mortality From Respiratory Syncytial Virus in Children Under 2 Years of Age:
A Prospective Community Cohort Study in Rural Maharashtra, India
02 Sep 2021
AbstractBackgroundAlthough respiratory syncytial virus (RSV) is the most important viral cause of
lower respiratory tract infection deaths in infants, there are few data on infant community deaths
caused by RSV.MethodsThis was an active surveillance of children younger than 2 years of age in 93
villages, 5 primary health centers, and 3 hospitals serving these villages
Respiratory Syncytial Virus–Associated Mortality Among Young Infants in
Karachi, Pakistan: A Prospective Postmortem Surveillance Study
02 Sep 2021
AbstractBackgroundRespiratory syncytial virus (RSV) is an important cause of infant morbidity and
mortality and a potential target for maternal immunization strategies. However, data on the role of
RSV in young infant deaths in developing countries are limited.MethodsWe conducted a community-
based mortality surveillance from August 2018–March 2020 for infants ≤6 months in Karachi,
Pakistan
Global Respiratory Syncytial Virus–Related Infant Community Deaths
02 Sep 2021
AbstractBackgroundRespiratory syncytial virus (RSV) is a leading cause of pediatric death, with
>99% of mortality occurring in low- and lower middle-income countries. At least half of RSV-related
deaths are estimated to occur in the community, but clinical characteristics of this group of children
remain poorly characterized
Community Mortality Due to Respiratory Syncytial Virus in Argentina:
Population-based Surveillance Study02 Sep 2021 AbstractBackgroundMany deaths in infants from low-middle income countries (LMICs) occur at home or upon arrival to health facilities. Although acute lower respiratory tract illness plays an important role in community mortality, the accuracy of mortality rates due to respiratory syncytial virus (RSV) remains unknown Deaths Attributed to Respiratory Syncytial Virus in Young Children in High– Mortality Rate Settings: Report from Child Health and Mortality Prevention Surveillance (CHAMPS) 02 Sep 2021 AbstractBackgroundLower respiratory tract infections are a leading cause of death in young children, but few studies have collected the specimens needed to define the role of specific causes. The Child Health and Mortality Prevention Surveillance (CHAMPS) platform aims to investigate causes of death in children aged
Increasing the PACE of characterising novel transporters by functional
genomics
05 Sep 2021
Publication date: December 2021Source: Current Opinion in Microbiology, Volume 64Author(s): Karl
A Hassan, Claire Maher, Liam DH Elbourne, Peter JF Henderson, Ian T Paulsen
[back to top]
Diagnostic Microbiology and Infectious Disease
Abbott ID NOW COVID-19 Assay Performance: A Year in Review
05 Sep 2021
Publication date: Available online 4 September 2021Source: Diagnostic Microbiology and Infectious
DiseaseAuthor(s): Phyu M. Thwe, Elphas Maiyo, Ping Ren
Impact of a Pharmacist-Facilitated, Evidence-Based Bundle Initiative on
Staphylococcus aureus Bacteremia Management
05 Sep 2021
Publication date: Available online 4 September 2021Source: Diagnostic Microbiology and Infectious
DiseaseAuthor(s): Wesley D. Kufel, Keri A. Mastro, Jeffrey M. Steele, Dongliang Wang, Scott W.
Riddell, Kristopher M. Paolino, Stephen J. Thomas
Violet colonies of Talaromyces marneffei produce on CHROMagar Candida
Medium
05 Sep 2021
Publication date: Available online 4 September 2021Source: Diagnostic Microbiology and Infectious
DiseaseAuthor(s): Xiu-Jiao Xia, Yan Zhong, Bo Sang, Qiu-Ping Li, Hui-Lin Zhi, Wen-Wen Lv, Hong
Shen, Ze-Hu Liu
[back to top]
Emerging Infectious Diseases Journal - ahead of print
SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during
First and Second Waves of Infections, South Africa, July 2020–March 2021
03 Sep 2021
J. Kleynhans et al.
Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus
Infection in Syrian Hamsters
01 Sep 2021
B. N. Williamson et al.
Equine Herpesvirus 1 Variant and New Marker for Epidemiologic
Surveillance, Europe, 2021
01 Sep 2021
G. Sutton et al.
Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of
SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers,
California, USA
01 Sep 2021
K. Surasi et al.
Probability-Based Estimates of Severe Acute Respiratory Syndrome
Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA
01 Sep 2021
M. H. Samore et al.
Socioeconomic Patterns of COVID-19 Clusters in Low-Incidence City, Hong
Kong
01 Sep 2021
G. Chung et al.Autochthonous Case of Rickettsia slovaca Infection in Russia
01 Sep 2021
R. F. Sayfullin et al.
Co-infection with Legionella and SARS-CoV-2, France, March 2020
01 Sep 2021
C. Allam et al.
Spontaneous Bacterial Peritonitis Caused by Bordetella hinzii
31 Aug 2021
G. C. Wang et al.
Mutations Associated with SARS-CoV-2 Variants of Concern, Benin, Early
2021
31 Aug 2021
A. Sander et al.
SARS-CoV-2 Delta Variant among Asiatic Lions, India
31 Aug 2021
A. Mishra et al.
Detection of SARS-CoV-2 in Wastewater at Residential College, Maine, USA,
August–November 2020
31 Aug 2021
Y. M. Brooks et al.
Widespread Disease in Hedgehogs (Erinaceus europaeus) Caused by
Toxigenic Corynebacterium ulcerans
31 Aug 2021
A. Martel et al.
Indoor and Outdoor Rodent Hosts of Orientia tsutsugamushi, Shandong
Province, China
31 Aug 2021
F. Li et al.
Natural Plasmodium inui Infections in Humans and Anopheles cracens
Mosquito, Malaysia
31 Aug 2021
J. Liew et al.
Genetic Characterization of Seoul Virus in the Seaport of Cotonou, Benin
31 Aug 2021
G. Castel et al.
Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis
Prophylaxis
31 Aug 2021
A. G. Puing et al.
Emergomyces orientalis Emergomycosis Diagnosed by Metagenomic Next-
Generation Sequencing
31 Aug 2021
D. He et al.
Fatal Systemic Capillary Leak Syndrome after SARS-COV-2Vaccination in
Patient with Multiple Myeloma
30 Aug 2021
G. Choi et al.
[back to top]
Eurosurveillance latest updates
A large outbreak of giardiasis in a municipality of the Bologna province, north-
eastern Italy, November 2018 to April 2019
02 Sep 2021Giardiasis, the disease caused by the flagellate Giardia duodenalis (syn. G.lamblia, G. intestinalis), is
the most commonly reported among the five food- and waterborne parasitic diseases under
mandatory surveillance in 24 EU countries. From November 2018 to April 2019, an outbreak of
giardiasis occurred in a municipality of the Bologna province, in north-eastern Italy
Vaccine effectiveness against infection with the Delta (B.1.617.2) variant,
Norway, April to August 2021
02 Sep 2021
Some variants of SARS-CoV-2 are associated with increased transmissibility, increased disease
severity or decreased vaccine effectiveness (VE). In this population-based cohort study
(n = 4,204,859), the Delta variant was identified in 5,430 (0.13%) individuals, of whom 84 were
admitted to hospital. VE against laboratory confirmed infection with the Delta variant was 22
Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against
SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
02 Sep 2021
The regional decline and rise of tick-borne encephalitis incidence do not
correlate with Lyme borreliosis, Austria, 2005 to 2018
02 Sep 2021
Background Tick-borne encephalitis (TBE) virus is a human pathogen that is expanding its endemic
zones in Europe, emerging in previously unaffected regions. In Austria, increasing incidence in alpine
regions in the west has been countered by a decline in traditional endemic areas to the east of the
country
Letter to the editor: More data on vaccine efficacy/effectiveness of COVID-19
vaccines against asymptomatic SARS-CoV-2 infection
02 Sep 2021
Erratum for Euro Surveill. 2021;26(31)
02 Sep 2021
[back to top]
Infection
Relationship between serotypes, disease characteristics and 30-day mortality
in adults with invasive pneumococcal disease
01 Sep 2021
Abstract Purpose Invasive pneumococcal disease (IPD) is responsible for substantial mortality and
morbidity worldwide. We aimed to identify host and bacterial factors associated with 30-day mortality
in 18-year-old patients hospitalized with IPD in France from 2013 to 2015
Lobar (croupous) pneumonia: old and new data
01 Sep 2021
Abstract Background and aim Pneumonia remains one of the most frequent death causes worldwide.
Among the etiological factors S. pneumoniae-causing lobar pneumonia plays a leading role.
According to current textbook knowledge at least three sequential stages of lobar pneumonia are
distinguished: congestion, red hepatization and gray hepatization
COVID-19 in young and middle-aged adults: predictors of poor outcome and
clinical differences
31 Aug 2021
Abstract Introduction Young and middle-aged adults are the largest group of patients infected with
SARS-CoV-2 and some of them develop severe disease. Objective To investigate clinical
manifestations in adults aged 18–65 years hospitalized for COVID-19 and identify predictors of poor
outcome
[back to top]
Infection Control & Hospital Epidemiology - FirstView ArticleThe impact of coronavirus disease 2019 (COVID-19) on healthcare-
associated infections in 2020: A summary of data reported to the National
Healthcare Safety Network
02 Sep 2021
Published online by Cambridge University Press:
Healthcare-associated infections during the coronavirus disease 2019
(COVID-19) pandemic
02 Sep 2021
Published online by Cambridge University Press:
[back to top]
International Journal of Infectious Diseases
Leprosy - an unusual cause of a suspicious nodule on mammography
05 Sep 2021
Publication date: Available online 4 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Christine Flis, Colan M. Ho-Yen, Alexander Polson, Ula Mahadeva, Stephen L.
Walker
Facial nerve palsy following the administration of COVID-19 mRNA vaccines:
analysis of self-reporting database
05 Sep 2021
Publication date: Available online 4 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, Tatsushi Toda, Atsushi Iwata,
Takeshi Iwatsubo
Arthralgia resolution rate following chikungunya virus infection
05 Sep 2021
Publication date: Available online 4 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Megan O'Driscoll, Henrik Salje, Aileen Y. Chang, Hugh Watson
VERTEBRAL OSTEOMYELITIS IN BACTERIAL MENINGITIS PATIENTS
05 Sep 2021
Publication date: Available online 4 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Fereshte Sheybani, Ana Helena A. Figueiredo, Matthijs C. Brouwer, Diederik van
de Beek
HIV Viral suppression Viral Load suppression following Intensive Adherence
counseling AMONG People living on treatment at MILITARY-Managed Health
Facilities in Uganda
03 Sep 2021
Publication date: Available online 2 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Bernard Kikaire, Michael Ssemanda, Alex Asiimwe, Miriam Nakanwagi, Gloria
Seruwagi, Stephen Lawoko, Evarlyne Asiimwe, Cassette Wamundu, Ambrose Musinguzi, Eric
Lugada, Twaha Rwegyema, Denis Bwayo
Evaluation of mass drug administration for schistosomiasis and soil-
transmitted helminths in school-aged children in Bankass, Mali
03 Sep 2021
Publication date: Available online 2 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Moussa Sangare, Adama Berthe, Housseini Dolo, Abdoul Fatao Diabaté,
Fatoumata dite Nènè Konipo, Lamine Soumaoro, Salif Seriba Doumbia, Michel Emmanuel Coulibaly,
Lamine Diarra, Yacouba Sanogo, Kueshivi Midodji Atsou, Abdallah Amadou Diallo, Siaka Yamoussa
Coulibaly, Modibo Keita,
Alterations of gut microbiota in patients with active pulmonary tuberculosis in
China: A pilot study
03 Sep 2021
Publication date: Available online 3 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Wenpei Shi, Yi Hu, Zhu Ning, Fan Xia, Meiying Wu, Yue O.O. Hu, Cheng Chen,
Stefanie Prast-Nielsen, Biao XusssHigh seroprevalence of SARS-CoV-2 but low infection fatality ratio eight
months after introduction in Nairobi, Kenya
03 Sep 2021
Publication date: Available online 2 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Isaac Ngere, Jeanette Dawa, Elizabeth Hunsperger, Nancy Otieno, Moses
Masika, Patrick Amoth, Lyndah Makayotto, Carolyne Nasimiyu, Bronwyn M. Gunn, Bryan Nyawanda,
Ouma Oluga, Carolyne Ngunu, Harriet Mirieri, John Gachohi, Doris Marwanga, Patrick K. Munywoki,
Dennis Odhiambo, Moshe D
SARS-CoV-2 infections in 165 countries over time
03 Sep 2021
Publication date: Available online 3 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Stilianos Louca
Faster decay of neutralizing antibodies in never infected than previously
infected healthcare workers three months after the second BNT162b2 mRNA
COVID-19 vaccine dose
02 Sep 2021
Publication date: Available online 2 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Ilaria Vicenti, Monica Basso, Francesca Gatti, Renzo Scaggiante, Adele Boccuto,
Daniela Zago, Eliana Modolo, Filippo Dragoni, Saverio Giuseppe Parisi, Maurizio Zazzi
On the First World Field Epidemiology Day, Honoring Our Disease Detectives
on the Front Lines
02 Sep 2021
Publication date: Available online 1 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Angela Hilmers
VISION-RELATED QUALITY OF LIFE AND DEPRESSION IN IN BRAZILIAN
PATIENTS WITH TOXOPLASMIC RETINOCHOROIDITIS
01 Sep 2021
Publication date: Available online 1 September 2021Source: International Journal of Infectious
DiseasesAuthor(s): Jacqueline Souza Dutra Arruda, Jacqueline Domingues Tibúrcio, Salvina Maria
de Campos-Carli, Antônio Lucio Teixeira, Daniel Vitor Vasconcelos-Santos
Nucleic acid amplification techniques for the detection of Schistosoma
mansoni infection in humans and the intermediate snail host: a structured
review and meta-analysis of diagnostic accuracy
31 Aug 2021
Publication date: Available online 30 August 2021Source: International Journal of Infectious
DiseasesAuthor(s): Hong-Mei Li, Zhi-Qiang Qin, Robert Bergquist, Men-Bao Qian, Shang Xia, Shan
Lv, Ning Xiao, Juerg Utzinger, Xiao-Nong Zhou
[back to top]
Journal of Clinical Microbiology
A hemagglutination-based, semi-quantitative test for point-of-care
determination of SARS-CoV-2 antibody levels
01 Sep 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Routine antigen testing is not a substitute for healthcare worker vaccination
against SARS-CoV-2
01 Sep 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Geographic variations in test reactivity for the serological diagnosis of
Trypanosoma cruzi infection
01 Sep 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Whole-genome sequencing evaluation of MALDI-TOF MS as a species
identification tool for Streptococcus suis01 Sep 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Xpert MTB/RIF Ultra is highly sensitive for the diagnosis of tuberculosis
lymphadenitis in an HIV-endemic setting
01 Sep 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
[back to top]
Journal of Clinical Virology
Torque-Teno virus to optimize timing of vaccination against severe acute
respiratory syndrome coronavirus 2 in solid organ transplant recipients
02 Sep 2021
High proportion of norovirus infection and predominance of GII.3[P12]
genotype among the children younger than 5 in Sabah, Malaysian Borneo
02 Sep 2021
Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2
variants
02 Sep 2021
[back to top]
Journal of Hospital Infection
Colonisation resistance against multidrug-resistant bacteria: a narrative
review
04 Sep 2021
Colonisation resistance by gut microbiota is a fundamental phenomenon in infection prevention and
control. Hospitalised patients may be exposed to multidrug-resistant bacteria when hand hygiene
compliance among healthcare workers is not adequate
Real-life measurement of size-fractionated aerosol concentration in a
plethysmography box during the COVID-19 pandemic and estimation of the
associated viral load
03 Sep 2021
There are concerns about pulmonary function tests (PFT) being associated with aerosol generation
and enhanced virus transmission. As a consequence, the number of PFTs was significantly reduced
during the COVID-19 pandemic. However, there are no robust data supporting this fear.
RE: ORAL ANTISEPTICS AGAINST CORONAVIRUS: IN-VITRO AND
CLINICAL EVIDENCE
03 Sep 2021
In a recent paper published in your journal; Mateos-Moreno MV, Mira A, Ausina-Márquez V, Ferrer
MD. Oral antiseptics against coronavirus: in-vitro and clinical evidence. J Hosp Infect. 2021
Jul;113:30-43. https://doi.org/10.1016/j.jhin.2021.04.004. Epub 2021 Apr 15
A hospital outbreak of an NDM-producing ST167 E. coli with a possible link to
a toilet
02 Sep 2021
In relation to a recent paper reporting toilet drain water as a potential source of hospital room-to-room
transmission of carbapenemase-producing Klebsiella pneumoniae [1], we would like to share a
similar experience from a Danish Hospital.
[back to top]
Journal of Infection
The high expression of SARS-CoV-2 cell receptors might lead to higher
COVID-19 infection rates in cancer patients02 Sep 2021
Dear Editor,
Adopting fresh air ventilation may reduce the risk of airborne transmission of
SARS-CoV-2 in COVID-19 unit
01 Sep 2021
Dear Editor,
On-treatment HBV RNA Dynamic Predicts Entecavir-induced HBeAg
Seroconversion in Children with Chronic Hepatitis B
30 Aug 2021
Despite preventive vaccination programs, significant numbers of children worldwide remain at risk of
contracting hepatitis B virus (HBV) and developing chronic hepatitis B (CHB)1. Adults CHB patients
have a 15 to 25% risk of dying from HBV-related liver disease, including liver cirrhosis and
hepatocellular carcinoma (HCC)2
Healthcare-associated COVID-19 in England: a national data linkage study
30 Aug 2021
Healthcare-associated (nosocomial) transmission was a salient feature of SARS (severe acute
respiratory syndrome) and MERS (Middle East respiratory syndrome) outbreaks, with 24% of SARS-
CoV-1 infections and 36% of MERS-CoV infections among hospitalised cases (excluding healthcare
workers) attributed to healthcare acquisition
SARS-CoV-2 variants with shortened incubation periods necessitate new
definitions for nosocomial acquisition
30 Aug 2021
To the Editors,
Dengue and Chikungunya Seroprevalence in waste pickers from the largest
Latin American open-air dump
30 Aug 2021
Dear editor,
Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults
in Sweden
30 Aug 2021
Variants of concern (VOC) have rapidly become the dominating SARS-CoV-2 viruses worldwide (1,
2). Concerns have been raised that VOC may cause more severe disease than non-VOC (3). Cevik
and Mishra (3) concluded that Alpha VOC (lineage B.1.1
[back to top]
Journal of Infection Prevention
Point prevalence of healthcare-associated infections and antibiotic use in a
tertiary care teaching hospital in Nepal: A cross-sectional study
30 Aug 2021
Journal of Infection Prevention, Ahead of Print. Information on the burden of healthcare-associated
infections (HAIs) and patterns of antibiotic use are prerequisites for infection prevention and control
(IPC) and antibiotics stewardship programmes
Environmental contamination and personal protective equipment
contamination with SARS-CoV-2 virus in a real-life clinical setting
30 Aug 2021
Journal of Infection Prevention, Ahead of Print. The importance of SARS-CoV-2 transmission via
contact routes and its stability on surfaces is becoming increasingly recognised. There is ongoing
concern that patients can become infected through person-to-person spread and environment-to-
person spread
[back to top]
Journal of Microbiology, Immunology and InfectionIn vitro activity of cefiderocol, cefepime/enmetazobactam,
cefepime/zidebactam, eravacycline, omadacycline, and other comparative
agents against carbapenem-non-susceptible Pseudomonas aeruginosa and
Acinetobacter baumannii isolates associated from bloodstream infection in
Taiwan between 2018–2020
05 Sep 2021
Publication date: Available online 4 September 2021Source: Journal of Microbiology, Immunology
and InfectionAuthor(s): Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, Po-Liang Lu, Yen-Hsu Chen, Shu-
Hsing Cheng, Min-Chi Lu, Chi-Ying Lin, Ting-Shu Wu, Muh-Yong Yen, Lih-Shinn Wang, Chang-Pan
Liu, Pei-Lan Shao, Yu-Lin Lee, Zhi-Yuan Shi, Yao-Shen Chen, Fu-Der Wang, Shu-Hui Tseng, Chao-
Nan Lin, Yu-Hui Chen
Enterobacterales species and non-fermenting Gram-negative bacteria from
different infection sources in Taiwan from 2016 to 2018
03 Sep 2021
Publication date: Available online 3 September 2021Source: Journal of Microbiology, Immunology
and InfectionAuthor(s): Shio-Shin Jean, Yu-Lin Lee, Po-Yu Liu, Min-Chi Lu, Wen-Chien Ko, Po-Ren
Hsueh
Multicenter study evaluating novel multi-specimen pooling assay for the
detection of SARS-CoV-2: high sensitivity and high throughput testing
03 Sep 2021
Publication date: Available online 2 September 2021Source: Journal of Microbiology, Immunology
and InfectionAuthor(s): Hsing-Yi Chung, Ming-Jr Jian, Chih-Kai Chang, Jung-Chung Lin, Kuo-Ming
Yeh, Chien-Wen Chen, Ya-Sung Yang, Shan-Shan Hsieh, En-Sung Chen, Mei-Hsiu Yang, Sheng-
Hui Tang, Cherng-Lih Perng, Ji-Rong Yang, Ming-Tsan Liu, Feng-Yee Chang, Hung-Sheng Shang
Respiratory etiological surveillance among quarantined patients with
suspected lower respiratory tract infection at a medical center in southern
Taiwan during COVID-19 pandemic
02 Sep 2021
Publication date: Available online 1 September 2021Source: Journal of Microbiology, Immunology
and InfectionAuthor(s): Chien-Ping Huang, Chin-Shiang Tsai, Po-Lan Su, Tang-Hsiu Huang, Wen-
Chien Ko, Nan-Yao Lee
Helminth Egg Analysis Platform (HEAP): An opened platform for microscopic
helminth egg identification and quantification based on the integration of deep
learning architectures
02 Sep 2021
Publication date: Available online 2 September 2021Source: Journal of Microbiology, Immunology
and InfectionAuthor(s): Chi-Ching Lee, Po-Jung Huang, Yuan-Ming Yeh, Pei-Hsuan Li, Cheng-Hsun
Chiu, Wei-Hung Cheng, Petrus Tang
Tuberculosis treatment delay and nosocomial exposure remain important
risks for patients undergoing regular hemodialysis
02 Sep 2021
Publication date: Available online 1 September 2021Source: Journal of Microbiology, Immunology
and InfectionAuthor(s): Michael Lu, Yuh-Mou Sue, Han-Lin Hsu, Jun-Fu Zhang, Yi-Jun Liu, Yu Chun
Yen, Tzu Yun Yu, Ming-Chih Yu, Chih-Hsin Lee
A potent antibody-secreting B cell response to Mycoplasma pneumoniae in
children with pneumonia
01 Sep 2021
Publication date: Available online 1 September 2021Source: Journal of Microbiology, Immunology
and InfectionAuthor(s): Wan-Chun Lai, Yu-Chia Hsieh, Yi-Ching Chen, Chen-Yen Kuo, Chih-Jung
Chen, Yhu-Chering Huang, Cheng-Hsun Chiu, Tzou-Yien Lin, Kuan-Ying A. Huang
[back to top]
Journal of Virology Current IssueIL-33-ILC2 axis represents a potential adjuvant target to increase the cross-
protective efficacy of influenza vaccine
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
The compound SBI-0090799 inhibits Zika virus (ZIKV) infection by blocking
de novo formation of the membranous replication compartment
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
PRRSV Nsp11 Antagonizes Broad Antiviral Effects of MCPIP1 via Inducing
IL-17 Expression
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Nectin-1 is an entry mediator for VZV infection of human neurons
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Skeletal muscle is an early site of Zika virus replication and injury impairing
myogenesis
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Intra and inter-cellular modeling of dynamic interaction between Zika virus
and its naturally occurring defective viral genomes
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
A novel attenuated enterovirus A71 mutant with VP1-V238A,K244R exhibits
reduced efficiency of cell entry/exit and augmented binding affinity to sulfated
glycans
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Repair of APOBEC3G-mutated retroviral DNA in vivo is facilitated by the host
enzyme uracil DNA glycosylase 2
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Multiple signals in the gut contract the mouse norovirus capsid to block
antibody binding while enhancing receptor affinity.
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Evaluation of a new viral vaccine vector in mice and rhesus macaques: J
paramyxovirus (JPV)-expressing HA of influenza A virus H5N1
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy
and vaccine product development
01 Sep 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
[back to top]
Microbiology and Molecular Biology Reviews: Current Issue
Viruses Defined by the Position of the Virosphere within the Replicator Space
01 Sep 2021
Microbiology and Molecular Biology Reviews, Ahead of Print.
[back to top]
Morbidity and Mortality Weekly Report (MMWR)EARLY RELEASE: Hospitalizations Associated with COVID-19 Among
Children and Adolescents - COVID-NET, 14 States, March 1, 2020-August
14, 2021
03 Sep 2021
COVID-19-associated hospitalization rates among children and adolescents increased with the Delta
variant.
EARLY RELEASE: Trends in COVID-19 Cases, Emergency Department
Visits, and Hospital Admissions Among Children and Adolescents Aged 0-17
Years - United States, August 2020-August 2021
03 Sep 2021
COVID-19 cases, emergency department visits, and hospital admissions in children and adolescents
aged 0-17 years increased during June to August 2021 and in states with lower vaccination
coverage.
National, Regional, State, and Selected Local Area Vaccination Coverage
Among Adolescents Aged 13-17 Years - United States, 2020
02 Sep 2021
This report describes adolescent vaccination coverage in 2020.
Screening Programs for SARS-CoV-2 Infections on a University Campus -
Austin, Texas, September 30-November 30, 2020
02 Sep 2021
This report describes COVID-19 screening programs among college students in Austin, Texas.
Evaluation of Syndromic Surveillance Data for Studying Harmful Algal Bloom-
Associated Illnesses - United States, 2017-2019
02 Sep 2021
This report describes emergency department visits related to harmful algal bloom exposure.
Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break
- Chicago, Illinois, March-May 2021
02 Sep 2021
This report describes an influx of COVID-19 cases at Chicago University following spring break 2021.
QuickStats: Death Rates from Colorectal Cancer, by Age Group - United
States, 1999-2019
02 Sep 2021
This report describes death rates from colorectal cancer in the United States.
EARLY RELEASE: Association Between COVID-19 and Myocarditis Using
Hospital-Based Administrative Data - United States, March 2020-January
2021
31 Aug 2021
Viral infections are a common cause of myocarditis. Some studies have indicated an association
between COVID-19 and myocarditis.
EARLY RELEASE: Epidemiologically Linked COVID-19 Outbreaks at a Youth
Camp and Men's Conference - Illinois, June-July 2021
31 Aug 2021
Linked COVID-19 outbreaks at two events: an overnight camp and a men's conference in Illinois,
June-July 2021.
[back to top]
Nature Reviews Microbiology - Current Issue
New keys to unlock the treasure trove of microbial natural products
03 Sep 2021
Nature Reviews Microbiology, Published online: 03 September 2021; doi:10.1038/s41579-021-
00631-7 This month’s Genome Watch highlights how recent advances in computational identification
of biosynthetic gene clusters (BGCs), and in their experimental manipulation, are opening new
avenues to access novel secondary metabolites.[back to top]
New England Journal of Medicine - Current Issue
Effectiveness of an Inactivated SARS-CoV-2 Vaccine
01 Sep 2021
New England Journal of Medicine, Volume 385, Issue 10, Page 946-948, September 2021.
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System
Workforce
01 Sep 2021
New England Journal of Medicine, Ahead of Print.
Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia
01 Sep 2021
New England Journal of Medicine, Volume 385, Issue 10, Page 885-895, September 2021.
[back to top]
Scandinavian Journal of Infectious Diseases: Table of Contents
Diagnostic accuracy of CT for COVID-19 Re: Diagnostic accuracy of
screening tests for patients suspected of COVID-19, a retrospective cohort
study
04 Sep 2021
.
Global epidemiology and changing clinical presentations of invasive
meningococcal disease: a narrative review
28 Aug 2021
.
Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2
antigen-detecting rapid test: does localisation or professional collection
matter?
27 Aug 2021
.
SARS-COV-2 seroprevalence among all healthcare workers in a tertiary
hospital in Spain
23 Aug 2021
.
Women report more symptoms and impaired quality of life: a survey of
Finnish COVID-19 survivors
19 Aug 2021
.
Utility of plasma cell-free DNA detection using homobifunctional imidoesters
using a microfluidic system for diagnosing active tuberculosis
18 Aug 2021
.
Evaluation of TB-LAMP assay for detection of Mycobacterium tuberculosis in
children
17 Aug 2021
.
Stenotrophomonas maltophilia bacteraemia: 61 cases in a tertiary hospital in
Denmark
15 Aug 2021
.
Molecular characterization of Staphylococcus aureus isolates derived from
severe pneumonia: a retrospective monocentre study12 Aug 2021
.
Carbapenemase-producing Enterobacterales infections in COVID-19 patients
12 Aug 2021
.
Emergency department testing is feasible but ineffective to eliminate hepatitis
C in Denmark
11 Aug 2021
.
An increased occurrence of viral hepatitis A during the COVID-19 pandemic
11 Aug 2021
.
Low morbidity in Danish patients with common variable immunodeficiency
disorder infected with severe acute respiratory syndrome coronavirus 2
10 Aug 2021
.
Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare
workers compared to elderly care staff in a Swedish low-prevalence region: a
cross-sectional study
05 Aug 2021
.
Risk factors of septic shock development and thirty-day mortality with a
predictive model in adult candidemia patients in intensive care units
31 Jul 2021
.
[back to top]
Sexually Transmitted Infection Online First
Call for emergency action to limit global temperature increases, restore
biodiversity and protect health
06 Sep 2021
Wealthy nations must do much more, much faster.The United Nations General Assembly in
September 2021 will bring countries together at a critical time for marshalling collective action to
tackle the global environmental crisis. They will meet again at the biodiversity summit in Kunming,
China, and the climate conference (Conference of the Parties (COP)26) in Glasgow, UK
Population rates of HIV, gonorrhoea and syphilis diagnoses by sexual
orientation in New Zealand
03 Sep 2021
IntroductionGlobally, gay and bisexual men (GBM) are over-represented in HIV, syphilis and
gonorrhoea cases. However, surveillance systems rarely provide meaningful measures of inequity,
such as population-specific rates, due to a lack of sexual orientation denominators
Clinical presentation and serological diagnosis of syphilis reinfection in men
living with HIV: a retrospective cohort study
02 Sep 2021
ObjectivesStudies on the characteristics of syphilis reinfection are scarce despite increasing numbers
and proportions of cases. We aimed to gain insights into the clinical and serological presentation of
reinfected men living with HIV and to evaluate diagnostic criteria for syphilis reinfection
[back to top]
NIS Affiliation
PubMed: NIS affiliationNational surveillance of bacterial and fungal coinfection and secondary
infection in COVID-19 patients in England: lessons from the first wave
05 Sep 2021
CONCLUSIONS: Coinfection/secondary bacterial/fungal infections were rare in non-hospitalized and
hospitalized persons with COVID-19, varied by ethnicity and age, and were associated with higher
mortality. However, the inclusion of non-hospitalized persons with asymptomatic/mild COVID-19
likely underestimated the rate of secondary bacterial/fungal infections
Ten-year longitudinal molecular epidemiology study of Escherichia coli and
Klebsiella species bloodstream infections in Oxfordshire, UK
04 Sep 2021
CONCLUSIONS: Our large genomic study highlights distinct differences in the molecular
epidemiology of E. coli and Klebsiella BSIs and suggests that no single specific pathogen genetic
factors (e.g. AMR/virulence genes/sequence type) are likely contributing to the increasing incidence
of BSI overall, that association with AMR genes in E. coli is a contributor to the increasing number of
E
Impact of the COVID-19 pandemic on the surveillance, prevention and control
of antimicrobial resistance: a global survey
02 Sep 2021
CONCLUSIONS: This was the first survey to explore the global impact of COVID-19 on AMR among
GLASS countries. Responses highlight important actions to help ensure that AMR remains a global
health priority, including engaging with GLASS to facilitate reliable AMR surveillance data, seizing the
opportunity to develop more sustainable IPC programmes, promoting integrated antibiotic
stewardship
Penetration and impact of COVID-19 in long term care facilities in England:
population surveillance study
01 Sep 2021
CONCLUSIONS: Over two-thirds of LTCFs have experienced large and widespread outbreaks of
COVID-19, and just under one-third of all COVID-19 deaths occurring in this setting in spite of early
policies. A key implication of our findings is upsurges in community incidences seemingly leading to
increased outbreaks in LTCFs; thus, identifying and shielding residents from key sources of infection
are
Staphylococcus argenteus transmission among healthy Royal Marines: a
molecular epidemiology case-study
01 Sep 2021
CONCLUSIONS: The identification of S. argenteus within a single troop from the total recruit
population suggests a common source for transmission, though high number of SNPs were identified,
both within-host and within-cluster. The high number of SNPs between some isolates may indicate a
common source of diverse isolates or a high level of S. argenteus mutation in carriage. S
Public preferences for delayed or immediate antibiotic prescriptions in UK
primary care: A choice experiment
30 Aug 2021
CONCLUSIONS: This study found that delayed prescription appears to be an acceptable approach to
reducing antibiotic consumption. Certain groups appear to be more amenable to delayed prescription,
suggesting particular opportunities for increased use of this strategy
[back to top]
Generated by Vable | Privacy PolicyYou can also read
